Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The CLEVER Study is a prospective, 2-arm, randomized, single-center pilot study to assess the
safety and efficacy of intensive blood pressure control using Clevidipine (on-label use) in
AIS patients undergoing standard of care mechanical thrombectomy (MT) within 24-hours of
symptoms onset.